{
  "id": "mhgap#risk_safety_7fabb652",
  "content": "In women and girls of childbearing potential with generalized onset seizures, lamotrigine\nor levetiracetam should be offered as first-line monotherapy.\nIf the first monotherapy is not successful for generalized onset seizures, an alternative\nfirst-line monotherapy should be tried.\nValproic acid (sodium valproate) is not recommended in women and girls of childbearing\npotential owing to the high risk of birth defects and neurodevelopmental disorders in\nchildren exposed to valproic acid (sodium valproate) in the womb.\nIf lamotrigine, levetiracetam and valproic acid (sodium valproate) are not available for\ngeneralized onset seizures, monotherapy with either phenytoin or phenobarbital can\nbe considered.\nStrong recommendation. High certainty of evidence.\nxxvi\nExecutive summary\nTABLE 1. (continued) Summary of recommendations\nModule and Recommendation\nrecommendation\nStrength of the recommendation and certainty of the evidence\nnumber\nEPI3 (update) 3.2 Focal onset seizures:\n(continued)\nMonotherapy with lamotrigine or levetiracetam should be offered as first-line treatment\nfor focal onset seizures in children and adults with epilepsy.\nIf neither lamotrigine nor levetiracetam are available, then carbamazepine should be\nused as an alternate first-line treatment for focal onset seizures in children and adults\nwith epilepsy.\nIf the first monotherapy is not successful for focal onset seizures, an alternative first-line\nmonotherapy should be tried.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety In women and girls of childbearing potential with generalized onset seizures, lamotrigine\nor levetiracetam should be offered as first-line monotherapy.\nIf the first monotherapy is not successful for generalized onset seizures, an alternative\nfirst-line monotherapy should be tried.\nValproic acid (sodium valproate) is not recommended in women and girls of childbearing\npotential owing to the high risk of birth defects and neurodevelopmental disorders in\nchildren exposed to valproic acid (sodium valproate) in the womb.\nIf lamotrigine, levetiracetam and valproic acid (sodium valproate) are not available for\ngeneralized onset seizures, monotherapy with either phenytoin or phenobarbital can\nbe considered.\nStrong recommendation. High certainty of evidence.\nxxvi\nExecutive summary\nTABLE 1. (continued) Summary of recommendations\nModule and Recommendation\nrecommendation\nStrength of the recommendation and certainty of the evidence\nnumber\nEPI3 (update) 3.2 Focal onset seizures:\n(continued)\nMonotherapy with lamotrigine or levetiracetam should be offered as first-line treatment\nfor focal onset seizures in children and adults with epilepsy.\nIf neither lamotrigine nor levetiracetam are available, then carbamazepine should be\nused as an alternate first-line treatment for focal onset seizures in children and adults\nwith epilepsy.\nIf the first monotherapy is not successful for focal onset seizures, an alternative first-line\nmonotherapy should be tried. In women and girls of childbearing potential with generalized onset seizures, lamotrigine\nor levetiracetam should be offered as first-line monotherapy. if the first monotherapy is not successful for generalized onset sei..."
}